These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27726357)

  • 21. X-ray snapshot of HIV-1 protease in action: observation of tetrahedral intermediate and short ionic hydrogen bond SIHB with catalytic aspartate.
    Das A; Mahale S; Prashar V; Bihani S; Ferrer JL; Hosur MV
    J Am Chem Soc; 2010 May; 132(18):6366-73. PubMed ID: 20397633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening.
    Amano Y; Tanabe E; Yamaguchi T
    Bioorg Med Chem; 2015 May; 23(10):2310-7. PubMed ID: 25862210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment Screening.
    Woolford AJ; Pero JE; Aravapalli S; Berdini V; Coyle JE; Day PJ; Dodson AM; Grondin P; Holding FP; Lee LY; Li P; Manas ES; Marino J; Martin AC; McCleland BW; McMenamin RL; Murray CW; Neipp CE; Page LW; Patel VK; Potvain F; Rich S; Rivero RA; Smith K; Somers DO; Trottet L; Velagaleti R; Williams G; Xie R
    J Med Chem; 2016 Jun; 59(11):5356-67. PubMed ID: 27167608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of signal peptide peptidase A with C-termini bound in the active sites: insights into specificity, self-processing, and regulation.
    Nam SE; Paetzel M
    Biochemistry; 2013 Dec; 52(49):8811-22. PubMed ID: 24228759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
    Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
    Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flap Dynamics in Aspartic Proteases: A Computational Perspective.
    Mahanti M; Bhakat S; Nilsson UJ; Söderhjelm P
    Chem Biol Drug Des; 2016 Aug; 88(2):159-77. PubMed ID: 26872937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.
    Ahmed W; Rani M; Khan IA; Iqbal A; Khan KM; Haleem MA; Azim MK
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):673-8. PubMed ID: 20063996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification, molecular characterization and gene expression analysis of an aspartic protease (Sc-ASP113) from the nematode Steinernema carpocapsae during the parasitic stage.
    Balasubramanian N; Toubarro D; Nascimento G; Ferreira R; Simões N
    Mol Biochem Parasitol; 2012; 182(1-2):37-44. PubMed ID: 22178695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit Lists.
    Schiebel J; Radeva N; Köster H; Metz A; Krotzky T; Kuhnert M; Diederich WE; Heine A; Neumann L; Atmanene C; Roecklin D; Vivat-Hannah V; Renaud JP; Meinecke R; Schlinck N; Sitte A; Popp F; Zeeb M; Klebe G
    ChemMedChem; 2015 Sep; 10(9):1511-21. PubMed ID: 26259992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
    Steuber H; Heine A; Klebe G
    J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pepsin-like aspartic protease (Sc-ASP155) cloning, molecular characterization and gene expression analysis in developmental stages of nematode Steinernema carpocapsae.
    Balasubramanian N; Nascimento G; Ferreira R; Martinez M; Simões N
    Gene; 2012 Jun; 500(2):164-71. PubMed ID: 22503896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming a Stable Amide into a Highly Reactive One: Capturing the Essence of Enzymatic Catalysis.
    Souza BS; Mora JR; Wanderlind EH; Clementin RM; Gesser JC; Fiedler HD; Nome F; Menger FM
    Angew Chem Int Ed Engl; 2017 May; 56(19):5345-5348. PubMed ID: 28378430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic activation of pre-substrates via dynamic fragment assembly on protein templates.
    Burda E; Rademann J
    Nat Commun; 2014 Nov; 5():5170. PubMed ID: 25403979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
    Amano Y; Yamaguchi T; Tanabe E
    Bioorg Med Chem; 2014 Apr; 22(8):2427-34. PubMed ID: 24656800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.
    Gómez J; Freire E
    J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of fragment screening by X-ray crystallography to beta-secretase.
    Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cleavage efficiency of the novel aspartic protease yapsin 1 (Yap3p) enhanced for substrates with arginine residues flanking the P1 site: correlation with electronegative active-site pockets predicted by molecular modeling.
    Olsen V; Guruprasad K; Cawley NX; Chen HC; Blundell TL; Loh YP
    Biochemistry; 1998 Mar; 37(9):2768-77. PubMed ID: 9485427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray analyses of aspartic proteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin.
    Blundell TL; Jenkins JA; Sewell BT; Pearl LH; Cooper JB; Tickle IJ; Veerapandian B; Wood SP
    J Mol Biol; 1990 Feb; 211(4):919-41. PubMed ID: 2179568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
    Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.
    Howard N; Abell C; Blakemore W; Chessari G; Congreve M; Howard S; Jhoti H; Murray CW; Seavers LC; van Montfort RL
    J Med Chem; 2006 Feb; 49(4):1346-55. PubMed ID: 16480269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.